Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/04/2003WO2003065017A3 A method and device to ascertain physical characteristics of porous media
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003061454A3 Automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease by optical imaging
09/04/2003WO2003054547A3 Diagnosis of dementia utilizing thrombospondin
09/04/2003WO2003053224A3 Novel compositions and methods for cancer
09/04/2003WO2003052424A3 Methods and means for modulating the immune response
09/04/2003WO2003051302A3 Methods and compositions for treatment of central nervous system disorders
09/04/2003WO2003048334A3 Immunocytokines with modulated selectivity
09/04/2003WO2003046566A3 Pedf biopolymer markers predictive of alzheimers disease
09/04/2003WO2003046560A3 Self-assembly molecules
09/04/2003WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease
09/04/2003WO2003045991A3 Complement c3 precursor biopolymer markers predictive of alzheimers disease
09/04/2003WO2003036267A3 Filtration system and method for obtaining a cytology layer
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003029816A3 Method for finding novel active ingredients having androgen-type properties
09/04/2003WO2003029800A3 Membrane-covered sensor for determining the concentration of oxygen and carbon dioxide
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003025578A3 Concentration of protein and/or peptides samples
09/04/2003WO2003023371A9 Method for adding an apparent non-signal line to a rapid diagnostic assay
09/04/2003WO2003020958A3 Campylobacter typing
09/04/2003WO2003019181A3 Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
09/04/2003WO2003019178A3 Method and apparatus for testing aldehyde in a polyester polymer
09/04/2003WO2003016875A3 Flow-cytometric axial pattern analysis of multicellular organisms
09/04/2003WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof
09/04/2003WO2003012724A9 System and method for quantitative assessment of joint diseases and the change over time of joint diseases
09/04/2003WO2003008978A3 Eosinophil prostaglandin d2 receptor assays
09/04/2003WO2003005890A3 Affinity biosensor for monitoring of biological process
09/04/2003WO2003003005A3 Method and circuitry for controlling and measuring electrical parameters in a biological membrane
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002101072A8 Letm1: modulators of cellular proliferation
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
09/04/2003WO2002097435A3 Assay method for platelet-activating factor
09/04/2003WO2002097398A3 Closed substrate platforms suitable for analysis of biomolecules
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002095054A3 Method of determining protein interaction inhibitors
09/04/2003WO2002089973A3 Affinity reaction probe detection/analysis chips and detection system and apparatus using the same
09/04/2003WO2002089733A3 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
09/04/2003WO2002082076A3 Renal cell carcinoma tumor markers
09/04/2003WO2002081749A3 Detection of aberrant dna methylation as marker for human cancer
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002077639A3 Osteocalcin fragments assay to monitor bone resorption
09/04/2003WO2002074923A3 Targets and screens for agents useful in controlling parasitic nematodes
09/04/2003WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof
09/04/2003WO2002070703A3 Cell visual characteristic-modifying sequences
09/04/2003WO2002066952A3 Mass defect labeling for the determination of oligomer sequences
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002062823A3 Peptides for facilitating composite receptor expression and translocation of macromolecules
09/04/2003WO2002061041A3 Solubility reporter gene constructs
09/04/2003WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof
09/04/2003WO2002055742A3 Rapid method for screening compounds for in vivo activity
09/04/2003WO2002054083A3 Alpha synuclein aggregation assays
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002049662A3 Use of the prion protein (prp) for suppression of bax-mediated apoptosis
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002043561A9 Measuring haematocrit in blood vessels
09/04/2003WO2002040995A3 Method for estimating metabolic function of xenobiotic and induction thereof
09/04/2003WO2002036807A3 Compositions and methods relating to breast specific genes and proteins
09/04/2003WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
09/04/2003WO2002031484A8 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry
09/04/2003WO2002024893A3 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
09/04/2003WO2002023201A3 Use of human phermone polypeptides
09/04/2003WO2002018643A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/04/2003WO2002016935A9 Screening method for discovering auxiliary agents promoting endocytosis
09/04/2003WO2002010741A3 Regional intestinal permeability model
09/04/2003WO2002010458A3 Method of performing subtractive hybridization
09/04/2003WO2002008456A3 Method for identifying metastatic tumor cells
09/04/2003WO2002002808A3 Method and nucleic acids for the analysis of astrocytomas
09/04/2003WO2002000932A3 Diagnosis of known genetic parameters within the mhc
09/04/2003WO2001098765A9 Multianalyte molecular analysis
09/04/2003WO2001096605A3 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
09/04/2003WO2001094629A3 Cancer gene determination and therapeutic screening using signature gene sets
09/04/2003WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001079840A3 Method and apparatus for selective biological material detection
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001058925A3 Protein separation and display
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2001055720A3 A system for developing assays for personalized medicine
09/04/2003US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
09/04/2003US20030167502 Human monoclonal antibodies to dendritic cells
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes
09/04/2003US20030167491 Inositol 1,4,5-triphosphate receptors (IP3R); ankyrin-B; for treatment of cardiac hypertrophy, diabetes, pancreas, respiratory system disorders, blood disorders, vision disorders, endocrine inbalance, and/or pain/inflammation
09/04/2003US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London
09/04/2003US20030167158 Font for displaying genetic information
09/04/2003US20030167157 Method for modelling asphaltenes flocculation conditions in hydrocarbon-containing fluids related to a reference fluid
09/04/2003US20030167136 Methods for identifying a molecule that may bind to a target molecule
09/04/2003US20030167135 Non-linear modelling of biological activity of chemical compounds
09/04/2003US20030167134 Determination radiation; biological warfare; culture product; polymerase chain reactions
09/04/2003US20030167133 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
09/04/2003US20030167132 Method and computer software product for predicting polyadenylation sites
09/04/2003US20030167129 Antiinflammatory agents; detecting binding to cellular library; separation; calibration
09/04/2003US20030167016 Airway-based cardiac output monitor and methods for using same
09/04/2003US20030166915 Retrovirus from the HIV group and its use
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166908 Seafood protein; measuring water absorption of fish bladder
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
1 ... 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 ... 3937